Essentials of Innovation Theory for Medical Devices

Löschner, Ulrike; Fleßa, Steffen

doi:10.1007/978-3-030-85653-3_3

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The focus of implant treatment is on maintaining the highest possible quality of life for patients, well into old age [5]. Especially given the scarce resources in the healthcare system necessitating a prioritization and rationing of healthcare services and goods, it is advisable to only launch or offer worthwhile products or services that have compelling benefits for patients [6,7]. In the existing literature, there is still scarce knowledge of the long-term experiences of individuals wearing CI, GI and CVI [8], and of how such experiences may affect patient preferences.…”

Section: Introductionmentioning

confidence: 99%

Patient Preferences for Long-Term Implant Care in Cochlear, Glaucoma and Cardiovascular Diseases

Schulz

Harzheim

Hübner

et al. 2023

IJERPH

View full text Add to dashboard Cite

In the process of developing and implementing innovative implant technologies the consideration of patient preferences can be beneficial for patients, doctors and developers. Nevertheless, in existing literature, there is still scarce knowledge of patients’ perspectives on long-term implant care. In this study, three discrete choice experiments (DCEs) were conducted in the context of cochlear implants (CI, n = 92), glaucoma implants (GI, n = 21) and cardiovascular implants (CVI, n = 23), examining the relative importance of attributes of long-term implant care from the patients’ perspective. The participants chose between differently shaped options for implant-related care. The attributes of these care options were generated and selected based on previous literature reviews, group discussions and a diary study with patients. The choice data were analyzed via binary logit regression. In CI-DCE, the technological compatibility of the implant with newer implant models, accessories or devices from other manufacturers was highly valued by participants, whereas in GI-DCE the (in)dependency on glaucoma medication post-implantation had the greatest influence on participants’ choice behavior. In CVI-DCE, the attribute with the highest relative importance related to the means of securing long-term treatment success. In all three DCE, shared decision making was relatively important for participants. Our results emphasized the importance of an adequate transfer of technological advancements in implant care for promoting patient benefits, such as the availability of comprehensible, understandable, high-quality information about current developments. Similarly, promoting technological health literacy and further pushing the technological compatibility, durability and safety of implants are directions for future implant development in accordance with patients’ preferences. Therefore, the participation of implant wearers in the development process is encouraged.

show abstract

Section: Introductionmentioning

confidence: 99%